Lee M, Ham H, Lee J, Lee E, Chung C, Kong D
Int J Mol Sci. 2024; 25(21).
PMID: 39518973
PMC: 11546992.
DOI: 10.3390/ijms252111420.
Shen S, Zhuang H
Medicine (Baltimore). 2024; 103(44):e40380.
PMID: 39496012
PMC: 11537654.
DOI: 10.1097/MD.0000000000040380.
Miwa A, Kamiya K
Molecules. 2024; 29(14).
PMID: 39064917
PMC: 11279660.
DOI: 10.3390/molecules29143339.
Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M
Mol Cancer. 2023; 22(1):189.
PMID: 38017433
PMC: 10683363.
DOI: 10.1186/s12943-023-01873-0.
Shi S, Wang K, Ugai T, Giannakis M, Cazaubiel J, Chan A
Br J Cancer. 2023; 129(11):1793-1800.
PMID: 37775523
PMC: 10667518.
DOI: 10.1038/s41416-023-02452-2.
Mechanism of TNFα-induced downregulation of salt-inducible kinase 2 in adipocytes.
Vavakova M, Hofwimmer K, Laurencikiene J, Goransson O
Sci Rep. 2023; 13(1):10559.
PMID: 37386070
PMC: 10310826.
DOI: 10.1038/s41598-023-37340-5.
The Effect of CacyBP/SIP on the Phosphorylation of ERK1/2 and p38 Kinases in Clear Cell Renal Cell Carcinoma.
Smereczanska M, Domian N, Mlynarczyk G, Kasacka I
Int J Mol Sci. 2023; 24(12).
PMID: 37373509
PMC: 10299707.
DOI: 10.3390/ijms241210362.
Germline mutations of B-Raf proto-oncogene and pathological implications in prostate cancer: observational study.
Tiabi I, Ennaji Y, Abumsimir B, Laraqui A, Ennibi K, Mrabti M
Ann Med Surg (Lond). 2023; 85(6):2628-2634.
PMID: 37363492
PMC: 10289590.
DOI: 10.1097/MS9.0000000000000685.
The cardiac glycoside ZINC253504760 induces parthanatos-type cell death and G2/M arrest via downregulation of MEK1/2 phosphorylation in leukemia cells.
Zhou M, Boulos J, Klauck S, Efferth T
Cell Biol Toxicol. 2023; 39(6):2971-2997.
PMID: 37322258
PMC: 10693532.
DOI: 10.1007/s10565-023-09813-w.
Biological Action of Singlet Molecular Oxygen from the Standpoint of Cell Signaling, Injury and Death.
Fujii J, Soma Y, Matsuda Y
Molecules. 2023; 28(10).
PMID: 37241826
PMC: 10223444.
DOI: 10.3390/molecules28104085.
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase.
Yamakawa K, Koyanagi-Aoi M, Machinaga A, Kakiuchi N, Hirano T, Kodama Y
Cancer Cell Int. 2023; 23(1):94.
PMID: 37198667
PMC: 10189913.
DOI: 10.1186/s12935-023-02928-4.
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
Rezaee M, Mohammadi F, Keshavarzmotamed A, Yahyazadeh S, Vakili O, Eshaghi Milasi Y
Front Pharmacol. 2023; 14:1152672.
PMID: 37153758
PMC: 10154547.
DOI: 10.3389/fphar.2023.1152672.
A stress-induced miR-31-CLOCK-ERK pathway is a key driver and therapeutic target for skin aging.
Yu Y, Zhang X, Liu F, Zhu P, Zhang L, Peng Y
Nat Aging. 2023; 1(9):795-809.
PMID: 37117623
DOI: 10.1038/s43587-021-00094-8.
Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma.
Li Q, Zhang X, Hu L, Ni B, Li D, Wang X
Nat Commun. 2023; 14(1):861.
PMID: 36792623
PMC: 9932171.
DOI: 10.1038/s41467-023-36521-0.
The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
Bai F, Du Q, Zou Q, Xu L, Dong W, Lv X
Cancer Rep (Hoboken). 2023; 6(4):e1782.
PMID: 36746394
PMC: 10075297.
DOI: 10.1002/cnr2.1782.
Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats.
Full Y, Wallasch C, Hilton A, Planz O
Front Pharmacol. 2022; 13:1050193.
PMID: 36545320
PMC: 9760738.
DOI: 10.3389/fphar.2022.1050193.
DDI2 promotes tumor metastasis and resists antineoplastic drugs-induced apoptosis in colorectal cancer.
Lei L, Cao Q, An G, Lv Y, Tang J, Yang J
Apoptosis. 2022; 28(3-4):458-470.
PMID: 36520320
DOI: 10.1007/s10495-022-01796-z.
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.
Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu J
Cancer Commun (Lond). 2022; 43(1):3-41.
PMID: 36424360
PMC: 9859735.
DOI: 10.1002/cac2.12392.
The functional role of p38 MAPK pathway in malignant brain tumors.
Grave N, Scheffel T, Cruz F, Rockenbach L, Goettert M, Laufer S
Front Pharmacol. 2022; 13:975197.
PMID: 36299892
PMC: 9589890.
DOI: 10.3389/fphar.2022.975197.
Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer.
Peng K, Zhang F, Wang Y, Sahgal P, Li T, Zhou J
Clin Cancer Res. 2022; 29(1):197-208.
PMID: 36278961
PMC: 9812865.
DOI: 10.1158/1078-0432.CCR-22-1609.